a Cohort Study of Ischemic Cerebrovascular Disease
ConditionIschaemic Stroke
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorXiangya Hospital of Central South University
About this trial
This study aims to establish a multicenter, large-scale, prospective cohort of patients with ischemic stroke. Various biological samples such as blood, feces, and urine are collected to identify biomarkers associated with ischemic stroke. By integrating demographic information, clinical indicators, imaging parameters, and biomarker parameters, the study aims to develop risk assessment, early warning, and prognosis prediction models. Additionally, the study aims to identify key genes and explore relevant signaling pathways related to ischemic stroke.
Eligibility criteria
Qualifiers
Clinical diagnosis of ischemic stroke.
Age ≥ 18 years.
Signed informed consent form.
Disqualifiers
Patients with moderate to severe mental disorders or dementia who cannot cooperate to complete the informed consent and follow-up procedures.
Patients with neurological functional impairment caused by conditions such as migraine aura, epilepsy, or other non-ischemic strokes.
Agitated patients who cannot cooperate with imaging examinations.
Pregnant or lactating patients, as well as those planning to become pregnant within 90 days.
Trial design
Treatments tested in this trial
- Intravenous thrombolysis
Treatment groups
5,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov